Amgen Inc. vs Pfizer Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Amgen Inc. is the larger company by market value: $249.2 B against $170.7 B for Pfizer Inc., 1.5 times as much (market caps of Oct 30, 2026).
- Pfizer Inc. had more revenue: $62.6 B against $36.8 B for Amgen Inc., both in the year to December 2025.
- Pfizer Inc. earned more: net income of $7.8 B against $7.7 B for Amgen Inc.
- Amgen Inc. keeps more of each dollar of sales: a net margin of 21.0% against 12.4% for Pfizer Inc.
- Pfizer Inc. employs more people: 75,000 against 25,200 at Amgen Inc. Each employee brings in about $1,458,373 of revenue at Amgen Inc. and $834,387 at Pfizer Inc.
- On price to earnings, Pfizer Inc. trades at 42.3× and Amgen Inc. at 26.5×: investors pay more for each dollar of Pfizer Inc.'s profit.
- Amgen Inc.'s revenue grew faster in its latest fiscal year: +9.9% against -1.6% for Pfizer Inc.
- On the Piotroski F-score, a nine-point test of improving finances, Amgen Inc. scores 7 and Pfizer Inc. 5.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Amgen Inc. AMGN · #74 in the world | Pfizer Inc. PFE · #127 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 1980 | 1849 |
| Size | ||
| Market cap | $249.2 B | $170.7 B |
| Revenue | $36.8 B | $62.6 B |
| Net income | $7.7 B | $7.8 B▲ best |
| Employees | 25,200 | 75,000 |
| Valuation | ||
| P/E ratio | 26.5× | 42.3× |
| Price to sales | 6.4× | 2.7× |
| Price to book | 28.8× | 2.0× |
| Free cash flow yield | 3.3% | 5.3%▲ best |
| Profitability | ||
| Gross margin | 67.3% | 74.3%▲ best |
| Operating margin | 24.7% | — |
| Net margin | 21.0%▲ best | 12.4% |
| Return on equity | 106.1%▲ best | 8.9% |
| Return on invested capital | 14.4% | — |
| Growth | ||
| Revenue growth | 9.9%▲ best | -1.6% |
| Revenue growth, 3 years a year | 11.8%▲ best | -14.8% |
| Earnings per share growth | 88.2%▲ best | -3.5% |
| Financial strength | ||
| Debt to equity | 6.3× | 0.7×▲ best |
| Net debt to EBITDA | 3.2× | — |
| Interest cover | 3.3× | — |
| Cash | ||
| Free cash flow margin | 22.0%▲ best | 14.5% |
| Shareholder returns | ||
| Dividend yield | 2.1% | — |
| Shareholder yield | 2.1% | — |
| Strength scores | ||
| Piotroski F-score | 7 of 9▲ best | 5 of 9 |
| Altman Z-score zone | grey | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Amgen Inc. or Pfizer Inc.?
Amgen Inc. is the larger company by market value: $249.2 B against $170.7 B for Pfizer Inc., 1.5 times as much (market caps of Oct 30, 2026).
Which makes more money, Amgen Inc. or Pfizer Inc.?
Pfizer Inc. had more revenue: $62.6 B against $36.8 B for Amgen Inc., both in the year to December 2025. Pfizer Inc. earned more: net income of $7.8 B against $7.7 B for Amgen Inc.
Which is more profitable, Amgen Inc. or Pfizer Inc.?
Amgen Inc. keeps more of each dollar of sales: a net margin of 21.0% against 12.4% for Pfizer Inc.
Which has more employees, Amgen Inc. or Pfizer Inc.?
Pfizer Inc. employs more people: 75,000 against 25,200 at Amgen Inc. Each employee brings in about $1,458,373 of revenue at Amgen Inc. and $834,387 at Pfizer Inc.
Is Amgen Inc. cheaper than Pfizer Inc.?
On price to earnings, Pfizer Inc. trades at 42.3× and Amgen Inc. at 26.5×: investors pay more for each dollar of Pfizer Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.
Which is growing faster, Amgen Inc. or Pfizer Inc.?
Amgen Inc.'s revenue grew faster in its latest fiscal year: +9.9% against -1.6% for Pfizer Inc.
Which is financially stronger, Amgen Inc. or Pfizer Inc.?
On the Piotroski F-score, a nine-point test of improving finances, Amgen Inc. scores 7 and Pfizer Inc. 5.